Related Experiment Videos
The problem of second cancers and the European experience with chemoprevention
1Department of Thoracic Surgery, Istituto Nazionale Tumori, Milan, Italy.
Lung Cancer (Amsterdam, Netherlands)
|November 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
European journal of cancer (Oxford, England : 1990)·2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Mechanical behavior of a total chest wall prosthesis with rib-like features.
Computer methods in biomechanics and biomedical engineering·2017
First-line camrelizumab plus chemotherapy followed by camrelizumab-apatinib maintenance for ES-SCLC: a single-arm phase II study.
Lung cancer (Amsterdam, Netherlands)·2026
Standard targeted therapy implementation for driver alterations newly identified by comprehensive genomic profiling in clinically driver-negative advanced NSCLC.
Lung cancer (Amsterdam, Netherlands)·2026
Discordance in pleural mesothelioma response classification and modelling of impact on clinical trials.
Lung cancer (Amsterdam, Netherlands)·2026
Reassessing surgical resection in small cell lung cancer in the multimodal treatment era.
Lung cancer (Amsterdam, Netherlands)·2026
Characterization of the genomic and transcriptomic landscape of invasive non-mucinous lung adenocarcinoma based on IASLC grading.
Lung cancer (Amsterdam, Netherlands)·2026
Molecular concordance and clonal dynamics of KRAS mutations in lung adenocarcinoma across distinct clinical scenarios.
Lung cancer (Amsterdam, Netherlands)·2026